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Brazil is a large country with approximately 200 million 
inhabitants and has 27 states in a total area of approximately 
8 million square kilometers. The distance from north to south 
is 3,645 km and from west to east is 3,577 km. The Brazilian 
population is of heterogeneous ethnic origin, with an intense 
process of miscegenation and a high degree of admixture 
between people of European, African, and Native American 
descent. Therefore, finding compatible blood to meet the 
needs of patients requiring rare blood has been a significant 
challenge in Brazil.
It is estimated that 3 million units of blood are collected 
per year in Brazil, with approximately 70 percent of donations 
collected through the public system. Despite numerous efforts 
performed by different institutions and professionals, until 
2014, there was no Brazilian national panel of rare donors—
although local programs, including private and public blood 
centers, have their own donor panels. The frozen stocks of 
rare units are kept in two centers with consolidated testing 
laboratories—the Albert Einstein Hospital and the Sírio 
Libanês Blood Center.
In a multi-ethnic population such as Brazil, the prevalence 
of the different blood group antigens vary significantly, and it 
is necessary to have a range of rare blood types available. Our 
main difficulty is in importing rare units through international 
rare donor registries, because Brazilian customs procedures 
are restrictive and bureaucratic. Because of this, collaborations 
between regional and local programs have helped us to meet 
the needs of the patients with a rare phenotype; for example, 
the local program run by the Sírio Libanês Hospital Blood Bank 
in São Paulo holds a special inventory of liquid and frozen red 
blood cell (RBC) units and has helped to fulfill many requests.
To meet most of the needs of patients, and considering the 
importance of having a national panel of rare donors in a large 
country like Brazil, in 2012, the Ministry of Health, through the 
General Coordination of Blood and Blood Products (CGSH), 
started and sponsored a project in partnership with the Albert 
Einstein Hospital to support three public blood centers located 
in strategic regions (south, north, and southeast Brazil). These 
centers have the potential to screen large numbers of donors 
for rare blood group antigens and platelets using serology 
and DNA typing and can freeze rare units. To encourage this 
initiative, and also as an incentive for the establishment of a 
national rare donor program, in November 2013, the Brazilian 
Association of Hematology and Hemotherapy, in conjunction 
with the International Society of Blood Transfusion (ISBT), 
organized an Academy Day on rare donors during the Brazilian 
Congress of Hematology and Cell Therapy (HEMO 2013), with 
positive repercussions throughout the country.
In May 2014, the Brazilian Ministry of Health, through the 
CGSH, established a technical committee to provide support 
for the implementation of a national rare donor program. 
At present, four blood centers located in strategic regions 
(Campinas, Florianópolis, Manaus, and Rio de Janeiro) were 
tasked with screening and freezing of rare red cells and 
platelets. Currently, these centers are starting the validation of 
cryopreservation procedures. A strategy for searching for and 
freezing rare units is being established by these four public 
blood centers and an extensive screening program for regional 
blood centers is being developed. Education of personnel, 
development of software, and creation of a process for 
requesting and shipping rare units have also been discussed. 
The role of the Brazilian national program, established by the 
CGSH, is to compile information on rare donors who have 
been identified at all blood centers in Brazil and to make this 
information available when rare blood is needed.
To start a national registry of rare donors, the CGSH 
conducted a survey at 17 public blood banks, which represent 
half of the Brazilian network of public blood centers. These 
regional blood banks do not have a screening program in 
place, but according to this survey, they have more than 1000 
active donors whose RBCs lack high-prevalence antigens, 
with more than 200 new rare donors identified between 2012 
and 2014. In this scenario, it is important to remember that 
the national program is still in the early phase and we are 
just implementing a rare donor database. We believe that the 
incentive from the government, together with the availability 
of resources for screening programs and the implementation 
of a countrywide network to establish the national rare donor 
registry, will significantly increase this database.
Surprisingly, we have five Rhnull donors identified in 
Brazil, including two group A sisters in the South of Brazil, 
two group O donors in Rio de Janeiro, and one group O donor 
in São Paulo. Sequencing of RH and RHAG of four of these 
donors showed that the two sisters have a deletion in RHCE*ce 
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(960-963 delG), one donor has the RHAG*01N.09 allele, and 
the other donor has the novel RHAG*01N.16 allele leading to a 
premature stop codon (Gln104Stop).
The rare units shipped domestically between 2012 and 
2014 are listed in Table 1. During this period, five requests 
were not fulfilled: Js(b–) (3); Yt(a–) (1); and K0 (1). Three 
incompatible transfusion cases were reported: two patients 
with anti-Jsb and one patient with anti-Yta. For those cases, only 
hydration and transfusion of small volumes were performed, 
with good survival of transfused RBCs. For the patients with 
anti-Jsb, a monocyte monolayer assay (MMA) was performed 
and the reactivity was less than 5 percent.
The profile of blood donors has changed in Brazil over the 
past 20 years, from remunerated to non-remunerated donors, 
and then from replacement to community donors. To ensure 
an adequate rare blood supply, it is crucial to recruit suitable 
blood donors. Recruitment campaigns and programs that 
educate such donors about the importance of blood donation 
have been developed. As incentives and motivation for the 
rare donors, the local and regional programs are organizing 
meetings with educational lectures and breakfast meetings. 
Recognition of the donors with letters, cards, and certificates 
or in the digital media is also being used as incentives.
Although the Brazilian national rare donor program is at 
an early stage and much work still needs to be done, we believe 
that soon we can have the program established.
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Table 1. Rare units shipped between 2012 and 2014 in Brazil
Phenotype Number of units shipped
k– 11
Di(b–) 5
S–s–U– 3
hrB– 3
Vel– 2
GE:–2 2
Lan– 1
Co(a–) 1
Oh (Bombay) 1
RH:–17 1
Rhnull 1
hrS– 1
r˝r˝ 1
Lu(b–) 1
